News
![Closeup of X-ray photography of human brain](https://pharmaphorum.com/wp-content/uploads/2016/07/Brain-scan-CNS.jpg)
Merck swings back into Alzheimer's with $1.1bn Cerevance all...
Merck & Co's earlier efforts to find new therapies for Alzheimer's disease resulted in failure, but the company is returning to the field via an R&D alliance with UK biotech Cerevan